Glenmark Pharmaceuticals Ltd. | Large-cap | Healthcare
₹1,711.20
-0.90%
| Glenmark Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 131.5B
Gross Profit 87.9B 66.88%
Operating Income 18.7B 14.19%
Net Income 10.5B 7.97%
EPS (Diluted) ₹37.11

Balance Sheet Metrics

Total Assets 160.5B
Total Liabilities 72.0B
Shareholders Equity 88.5B
Debt to Equity 0.81

Cash Flow Metrics

Operating Cash Flow 2.1B
Free Cash Flow -15.8B

Revenue & Profitability Trend

Glenmark Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 131.5B 116.4B 114.3B 121.7B 108.1B
Cost of Goods Sold 43.5B 48.8B 45.9B 47.8B 40.0B
Gross Profit 87.9B 67.6B 68.5B 74.0B 68.1B
Operating Expenses 35.9B 26.7B 25.9B 25.6B 22.9B
Operating Income 18.7B 6.3B 10.8B 18.4B 17.2B
Pre-tax Income 14.0B 365.0M 2.4B 14.4B 13.8B
Income Tax 3.5B 18.7B 3.3B 4.5B 4.1B
Net Income 10.5B -14.3B 3.8B 9.9B 9.7B
EPS (Diluted) ₹37.11 -₹53.22 ₹10.53 ₹33.37 ₹34.38

Income Statement Trend

Glenmark Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 93.0B 74.3B 107.3B 82.8B 73.6B
Non-Current Assets 67.5B 69.3B 86.5B 88.0B 82.4B
Total Assets 160.5B 143.6B 193.7B 170.8B 156.0B
Liabilities
Current Liabilities 59.7B 58.2B 51.1B 46.9B 42.0B
Non-Current Liabilities 12.3B 6.9B 44.3B 29.6B 43.4B
Total Liabilities 72.0B 65.1B 95.3B 76.5B 85.4B
Equity
Total Shareholders Equity 88.5B 78.5B 98.4B 94.4B 70.6B

Balance Sheet Composition

Glenmark Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 14.0B 5.7B 8.7B 14.4B 13.8B
Operating Cash Flow 2.1B 19.1B 7.3B 12.7B 11.5B
Investing Activities
Capital Expenditures -7.5B -9.0B -5.5B -7.9B -6.8B
Investing Cash Flow -400.3M 45.4B -5.5B -3.4B -6.8B
Financing Activities
Dividends Paid -704.4M -1.2B -1.4B -927.0M -704.5M
Financing Cash Flow 11.3B -32.8B 3.4B -1.7B -514.8M
Free Cash Flow -15.8B -11.6B 176.3M 3.2B 3.6B

Cash Flow Trend

Glenmark Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 45.35
Forward P/E 39.66
Price to Book 5.53
Price to Sales 3.54
PEG Ratio 39.66

Profitability Ratios

Profit Margin 7.79%
Operating Margin 13.69%
Return on Equity 12.54%
Return on Assets 8.14%

Financial Health

Current Ratio 1.56
Debt to Equity 27.94
Beta 0.20

Per Share Data

EPS (TTM) ₹37.15
Book Value per Share ₹304.50
Revenue per Share ₹476.16

Financial data is updated regularly. All figures are in the company's reporting currency.